Capsure Sense
Device Leads
PDI 00643169590519
General payments
$3,773
Research payments
$16,711,909
Through program year 2025, $3,773 in general payments and $16,711,909 in research payments were reported against Capsure Sense (Leads).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $728 | 8 |
| 2024 | General | $221 | 16 |
| 2024 | Research | $4,631,499 | 1,557 |
| 2023 | General | $1,199 | 29 |
| 2023 | Research | $3,854,344 | 1,337 |
| 2022 | General | $706 | 29 |
| 2022 | Research | $4,511,236 | 1,763 |
| 2021 | General | $920 | 32 |
| 2021 | Research | $3,714,830 | 1,439 |
Breakdown
The top 5 of 8 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
114 general · 6,096 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.